BACKGROUND: Sickle cell disorder is a haemoglobinopathy prevalent in the Vidharbha region of Maharashtra, central India. With recent evidence of oxidative stress in sickle haemoglobinopathy, a possible deficiency of antioxidant vitamins was suspected. METHODS: We measured plasma vitamin E, vitamin C and beta-carotene levels in persons with heterozygous (n=80) and homozygous sickle cell state (n=20), and suitable healthy controls for these groups (n=100 and 66, respectively) in a community-based study in the villages near our institution. RESULTS: Subjects with heterozygous sickle cell trait had lower vitamin E levels than their respective controls (p < 0.05). Subjects with homozygous sickle cell disease had lower levels of all three vitamins (p < 0.05). Vitamins E and C levels showed a significant positive correlation in both forms of sickle cell disorder. CONCLUSION: Our findings suggest that there is depletion of the antioxidant vitamins, particularly in severe forms of sickle cell disorder. A trial of administration of therapeutic doses of vitamin E in this condition is warranted.
BACKGROUND:Sickle cell disorder is a haemoglobinopathy prevalent in the Vidharbha region of Maharashtra, central India. With recent evidence of oxidative stress in sickle haemoglobinopathy, a possible deficiency of antioxidant vitamins was suspected. METHODS: We measured plasma vitamin E, vitamin C and beta-carotene levels in persons with heterozygous (n=80) and homozygous sickle cell state (n=20), and suitable healthy controls for these groups (n=100 and 66, respectively) in a community-based study in the villages near our institution. RESULTS: Subjects with heterozygous sickle cell trait had lower vitamin E levels than their respective controls (p < 0.05). Subjects with homozygous sickle cell disease had lower levels of all three vitamins (p < 0.05). Vitamins E and C levels showed a significant positive correlation in both forms of sickle cell disorder. CONCLUSION: Our findings suggest that there is depletion of the antioxidant vitamins, particularly in severe forms of sickle cell disorder. A trial of administration of therapeutic doses of vitamin E in this condition is warranted.
Authors: Alex George; Suvarnamala Pushkaran; Diamantis G Konstantinidis; Sebastian Koochaki; Punam Malik; Narla Mohandas; Yi Zheng; Clinton H Joiner; Theodosia A Kalfa Journal: Blood Date: 2013-01-24 Impact factor: 22.113
Authors: Susan Claster; John C Wood; Leila Noetzli; Susan M Carson; Thomas C Hofstra; Rachna Khanna; Thomas D Coates Journal: Am J Hematol Date: 2009-06 Impact factor: 10.047
Authors: Charles Antwi-Boasiako; Gifty B Dankwah; Robert Aryee; Charles Hayfron-Benjamin; Eric S Donkor; Andrew D Campbell Journal: Med Sci (Basel) Date: 2019-01-25
Authors: Shahida A Khan; Ghazi A Damanhouri; Tahir J Ahmed; Saeed H Halawani; Ashraf Ali; Ahmad Makki; Sarah A Khan Journal: J Pediatr (Rio J) Date: 2022-02-06 Impact factor: 2.990
Authors: Shahida A Khan; Ghazi Damanhouri; Ashraf Ali; Sarah A Khan; Aziz Khan; Ahmed Bakillah; Samy Marouf; Ghazi Al Harbi; Saeed H Halawani; Ahmad Makki Journal: Nutr Metab (Lond) Date: 2016-08-08 Impact factor: 4.169
Authors: Atinuke Dosunmu-Ogunbi; Shuai Yuan; Daniel J Shiwarski; Joshua W Tashman; Michael Reynolds; Adam Feinberg; Enrico M Novelli; Sruti Shiva; Adam C Straub Journal: Function (Oxf) Date: 2022-02-17